CMS proposes rules to improve Medicaid drug price transparency
(By Rylee Wilson for Becker’s Hospital Review) CMS is proposing a set of rules for drug manufacturers, pharmaceutical benefit managers
Read More(By Rylee Wilson for Becker’s Hospital Review) CMS is proposing a set of rules for drug manufacturers, pharmaceutical benefit managers
Read More(By Rylee Wilson for Becker’s Hospital Review) Insurer groups say hospitals are to blame for higher costs of specialty drugs,
Read More(By Arthur Allen for Kaiser Health News) Eli Lilly & Co.’s announcement that it is slashing prices for its major
Read More